-10.90 (-0.92%) Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s receives positive CHMP opinion from European Medicines Agency for its proposed Rituximab biosimilar’.
The above information is a part of company’s filings submitted to BSE.